The 2023 Rosenman Innovator raised $6M in funding to expand its virtual dermatology clinic services The 2023 Rosenman Innovator raised […]
Piction Health Raises $6M to Revolutionize Dermatological Care with AI Innovation
Category: Startup News
Midi Health Secures $60M Series B to Transform Perimenopause and Menopause Care
2022 ADAPT Finalist, Midi Health, closed a $60M Series B funding round San Francisco – 2022 ADAPT Finalist, Midi Health, […]
FDA Grants Breakthrough Device Status to the 2022 Rosenman Innovator, Efemoral Medical
Efemoral Medical is a 2022 Rosenman Innovator and developer of the Efemoral Vascular Scaffold System (EVSS) for the treatment of peripheral […]
Bloomlife, a 2019 Rosenman Innovator Announces FDA Clearance of Bloomlife MFM-Pro
Bloomlife, a 2019 Rosenman Innovator and award winning maternal health company, has gained FDA clearance for their first maternal and […]
2023 Rosenman ADAPT Finalist, Isaac Health Raises $5.7M
2023 ADAPT Finalist, Isaac Health, successfully completed an oversubscribed $5.7 million Seed round to redefine the future of brain healthcare […]
FDA Clearance for Diabetic Neuropathy Treatment
The FDA has granted clearance to Neuralace Medical’s Axon Therapy to treat chronic pain related to nerve damage caused by […]
Nest Collaborative Raises $6M to Revolutionize Virtual Lactation Support
Nest Collaborative, a 2023 Rosenman Innovator and premier virtual lactation support platform, has secured $6M in funding, bringing its total […]
FDA Clearance Marks Milestone in Real-Time Skin Cell Visualization
Enspectra Health, a 2018 Rosenman Innovator, announced FDA clearance for the VIO System, which has tremendous potential for evaluating skin […]
$9.9M Secured to Transform Diabetes Care
Encellin has secured $9.9M in financing to advance its groundbreaking Encapsulated Cell Replacement Therapy (EnCRT) for Type 1 Diabetes (T1D). […]
A Joint Investment
2020 Rosenman Innovator, Nanochon, received an investment for their regenerative cartilage technology. The investment will enable Nanochon to continue development […]